{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T04:03:29Z","timestamp":1742875409611,"version":"3.40.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"DOI":"10.1186\/s40814-025-01614-8","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:43:45Z","timestamp":1742802225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mobile telephone contingency management to encourage adherence to supervised medication among individuals most at risk of non-adherence to opioid agonist treatment: a study protocol for a feasibility study (TIES2)"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-1703","authenticated-orcid":false,"given":"Nicola","family":"Metrebian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol-Ann","family":"Getty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Pilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"1614_CR1","unstructured":"Office for Health Improvement and Disparities. Substance misuse treatment for adults: statistics 2020 to 2021. Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS). Office for Health Improvement and Disparities. 2021. https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2020-to-2021.\u00a0Acessed 14 Mar 2025."},{"key":"1614_CR2","unstructured":"World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009 WHO Library."},{"key":"1614_CR3","unstructured":"Strang J, Drummond C, McNeill A, Lader M, Marsden J. Chapter 16. Addictions, dependence and substance abuse. In: Annual report of the Chief Medical Officer 2013, Public mental health priorities: investing in the evidence."},{"key":"1614_CR4","unstructured":"NICE National Institute for Care Excellence (NICE) Drug Misuse 2006 Methadone and buprenorphine for the management of opioid dependence. NICE Technology Appraisal guidance [TA114]. 2007."},{"issue":"6","key":"1614_CR5","doi-asserted-by":"crossref","first-page":"2004697","DOI":"10.1111\/j.1360-0443.2004.00752.x","volume":"99","author":"C Godfrey","year":"2004","unstructured":"Godfrey C, Steward D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2 year outcome data from National Treatment Outcome Research Study (NTORS). Addiction. 2004;99(6):2004697\u2013707.","journal-title":"Addiction"},{"key":"1614_CR6","volume-title":"Reducing drug related deaths","author":"Advisory Council on the Misuse of Drugs","year":"2000","unstructured":"Advisory Council on the Misuse of Drugs. Reducing drug related deaths. London: HMSO; 2000."},{"key":"1614_CR7","doi-asserted-by":"publisher","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database BMJ. 2010;341:c5475. https:\/\/doi.org\/10.1136\/bmj.c5475.","DOI":"10.1136\/bmj.c5475"},{"key":"1614_CR8","unstructured":"Department of Health and Social Care. And devolved administrations. Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group, Drug misuse and dependence: UK guidelines on clinical management. London Department of Health (2017)."},{"key":"1614_CR9","volume-title":"Clinical guidelines on drug misuse and dependence independent expert working group, drug misuse and dependence: UK guidelines on clinical management","author":"Department of Health","year":"1999","unstructured":"Department of Health. Clinical guidelines on drug misuse and dependence independent expert working group, drug misuse and dependence: UK guidelines on clinical management. London: Department of Health; 1999."},{"key":"1614_CR10","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","volume":"341","author":"J Strang","year":"2010","unstructured":"Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993\u20132008): analyses using OD4 index in England and Scotland. BMJ. 2010;341:c4851.","journal-title":"BMJ"},{"key":"1614_CR11","unstructured":"ONS. Statistical bulletin: deaths related to drug poisoning in England and Wales, 2012. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2013-08-28."},{"key":"1614_CR12","unstructured":"Office for National Statistics Statistical bulletin. Deaths related to drug poisoning in England and Wales: 2019 registrations 14.10.2020. Office of National Statistics."},{"key":"1614_CR13","unstructured":"Department of Health and Social Care and Public Health. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol. 2020. https:\/\/www.gov.uk\/government\/publications\/covid-19-guidance-for-commissioners-and-providers-ofservices-for-people-who-use-drugs-oralcohol."},{"key":"1614_CR14","unstructured":"National Drug Evidence Centre Statistics from the National Drug Treatment Monitoring System (NDTMS). 2020."},{"key":"1614_CR15","unstructured":"Aldabergenov D. Evaluation of the switch from daily supervised consumption. Society for the study of addiction. Video Poster 2021. https:\/\/www.addiction-ssa.org\/author-publications\/evaluation-of-the-switch-from-daily-supervised-consumption-to-take-home-prescriptions-of-methadone-on-methadone-related-mortality-during-the-national-lockdown-due-to-the-covid-19-pandemic\/. Accessed 06.02.2024."},{"key":"1614_CR16","unstructured":"Department of Health and Social Care and Public Health. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol. 2021. https:\/\/www.gov.uk\/government\/collections\/alcohol-and-drug-misuseprevention-and-treatment-guidance. Accessed 08.11.2021."},{"key":"1614_CR17","unstructured":"Metrebian, et al. TIES final report NIHRPB-PG-0815\u201310162 NIHR. 2019."},{"key":"1614_CR18","unstructured":"Skinner BF. The behavior of organisms: an experimental analysis.\u00a0Appleton-Century-Crofts, USA; 1966."},{"key":"1614_CR19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","volume":"101","author":"M Prendergast","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwall L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101:1546\u201360.","journal-title":"Addiction"},{"issue":"10","key":"1614_CR20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2021.1969","volume":"78","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SR, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(10):1092\u2013102.","journal-title":"JAMA Psychiat"},{"key":"1614_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","volume":"101","author":"JP Lussier","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192\u2013203.","journal-title":"Addiction"},{"issue":"1","key":"1614_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(99)00068-X","volume":"58","author":"JD Griffith","year":"2000","unstructured":"Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58(1):55\u201366.","journal-title":"Drug Alcohol Depend"},{"key":"1614_CR23","doi-asserted-by":"publisher","unstructured":"Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder.\u00a0Cochrane Database Syst Rev. 2016(5):CD005336. https:\/\/doi.org\/10.1002\/14651858.CD005336.pub4.","DOI":"10.1002\/14651858.CD005336.pub4"},{"issue":"9","key":"1614_CR24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/add.12589","volume":"109","author":"LA Benishek","year":"2014","unstructured":"Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, Festinger DS. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109(9):1426\u201336.","journal-title":"Addiction"},{"key":"1614_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2013.06.005","volume":"133","author":"MBR Kidorf","year":"2013","unstructured":"Kidorf MBR, Gandotra N, et al. Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial. Drug Alcohol Dependence. 2013;133:30.","journal-title":"Drug Alcohol Dependence"},{"key":"1614_CR26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1037\/ccp0000208","volume":"85","author":"RLBR Schacht","year":"2017","unstructured":"Schacht RLBR, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult ClinPsychol. 2017;85:689.","journal-title":"J Consult ClinPsychol"},{"issue":"1","key":"1614_CR27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drugalcdep.2013.05.028","volume":"133","author":"W Chen","year":"2013","unstructured":"Chen W, Hong Y, Zou X, McLaughlin MM, Xia Y, Ling L. Effectiveness of prize-based contingency management in a methadone maintenance program in China. Drug Alcohol Dependence. 2013;133(1):270\u20134.","journal-title":"Drug Alcohol Dependence"},{"key":"1614_CR28","doi-asserted-by":"crossref","first-page":"108556","DOI":"10.1016\/j.jsat.2021.108556","volume":"133","author":"RA Pfund","year":"2022","unstructured":"Pfund RA, Ginlet MK, Rash CI, Zajac K. Contingency management for treatment attendance: a meta-analysis. J Subst Abuse Treat. 2022;133: 108556.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"1614_CR29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjmed.2012.01.003","volume":"125","author":"NM Petry","year":"2012","unstructured":"Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888\u201396.","journal-title":"Am J Med"},{"issue":"9","key":"1614_CR30","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s10461-019-02592-8","volume":"23","author":"K Silverman","year":"2019","unstructured":"Silverman K, Holtyn AF, Rodewald AM, et al. Incentives for viral suppression in people living with HIV: a randomized clinical trial. AIDS Behav. 2019;23(9):2337\u201346.","journal-title":"AIDS Behav"},{"key":"1614_CR31","doi-asserted-by":"crossref","unstructured":"Tulsky JP, Pilote L, Hahn. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000;160:697\u2013702.","DOI":"10.1001\/archinte.160.5.697"},{"issue":"9938","key":"1614_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","volume":"384","author":"T Weaver","year":"2014","unstructured":"Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, et al. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. The Lancet. 2014;384(9938):153\u201363.","journal-title":"The Lancet"},{"issue":"7","key":"1614_CR33","doi-asserted-by":"crossref","first-page":"e046371","DOI":"10.1136\/bmjopen-2020-046371","volume":"11","author":"N Metrebian","year":"2021","unstructured":"Metrebian N, Weaver T, Goldsmith K, Pilling S, et al. Using a pragmatically adapted, low-cost, contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. BMJ Open. 2021;11(7):e046371.","journal-title":"BMJ Open"},{"issue":"5","key":"1614_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jval.2022.11.021","volume":"26","author":"J Shearer","year":"2023","unstructured":"Shearer J, Metrebian N, Weaver T, Goldsmith K, Strang J, Pilling S, Mitcheson L, Day E, Dunn J, Glasper A, Akhtar S, Bajaria J, Charles V, Desai R, Haque F, Little N, McKechnie H, Mosler F, Mutz J, Poovendran D, Byford S. The cost-effectiveness of financial incentives to achieve heroin abstinence in individuals with heroin use disorder starting new treatment episodes: a cluster randomized trial-based economic evaluation. Value Health. 2023;26(5):658\u201365. https:\/\/doi.org\/10.1016\/j.jval.2022.11.021. Epub 2022 Dec 9 PMID: 36509367.","journal-title":"Value Health"},{"key":"1614_CR35","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/add.13385","volume":"111","author":"R Rafia","year":"2016","unstructured":"Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction. 2016;111:1616\u201327. https:\/\/doi.org\/10.1111\/add.13385.","journal-title":"Addiction"},{"key":"1614_CR36","unstructured":"National Institute for Health and Care Excellence (NICE) Drug misuse in over 16s. Psychosocial Interventions. NICe Guidelines[CG51]. 2007."},{"key":"1614_CR37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108425","volume":"126","author":"AS Hammond","year":"2021","unstructured":"Hammond AS, Sweeney MM, Chikosi TU, Stitzer ML. Digital delivery of a contingency management intervention for substance use disorder: a feasibility study with DynamiCare Health. J Subst Abuse Treat. 2021;126:108425.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"1614_CR38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/add.14725","volume":"114","author":"CA Getty","year":"2019","unstructured":"Getty CA, Morande A, Lynskey M, Weaver T, Metrebian N. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis. Addiction. 2019;114(11):1915\u201325.","journal-title":"Addiction"},{"key":"1614_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drugalcdep.2006.09.019","volume":"88","author":"JL Sorensen","year":"2007","unstructured":"Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88:54\u201363. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.09.019.","journal-title":"Drug Alcohol Depend"},{"key":"1614_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.drugalcdep.2008.09.017","volume":"100","author":"PG Barnett","year":"2009","unstructured":"Barnett PG, Sorensen JL, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009;100:115\u201321. https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.09.017.","journal-title":"Drug Alcohol Depend"},{"key":"1614_CR41","doi-asserted-by":"crossref","unstructured":"DeFulio A, Devoto A, Traxler H, Cosottile, Fingerhood M, Nuzzo P, Dallery J. Smartphone-based incentives for promoting adherence to antiretroviral therapy: a randomized controlled trial. Prev Med Rep. 2021;21:101318.","DOI":"10.1016\/j.pmedr.2021.101318"},{"key":"1614_CR42","volume":"120","author":"A DeFulio","year":"2020","unstructured":"DeFulio A, Rzeszutek MJ, Furgeson J, Ryan S, Rezania S. A smartphone-smartcard platform for contingency management in an inner-city substance use disorder outpatient program. J Subst Abuse Treat. 2020;120: 108188.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"1614_CR43","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/ntr\/ntt060","volume":"15","author":"JS Hertzberg","year":"2013","unstructured":"Hertzberg JS, Carpenter VL, Kirby AC, Calhoun PS, Moore SD, Dennis MF, et al. Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder. Nicotine Tob Res. 2013;15(11):1934\u20138.","journal-title":"Nicotine Tob Res"},{"key":"1614_CR44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40814-020-00761-4","volume":"7","author":"N Metrebian","year":"2021","unstructured":"Metrebian N, Carr E, Goldsmith K, Weaver T, Pilling S, Shearer J, et al. Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES). Pilot and Feasibility Studies. 2021;7:14.","journal-title":"Pilot and Feasibility Studies"},{"key":"1614_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.drugalcdep.2014.11.001","volume":"146","author":"J Milward","year":"2015","unstructured":"Milward J, Day E, Wadsworth E, Strang J, Lynskey M. Mobile phone ownership, usage and readiness to use by patients in drug treatment. Drug Alcohol Depend. 2015;146:111\u20135. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.001.","journal-title":"Drug Alcohol Depend"},{"key":"1614_CR46","unstructured":"Mindwave Ventures Ltd. TIES Project. King\u2019s College London and South London and Maudsley NHS Foundation Trust."},{"key":"1614_CR47","doi-asserted-by":"publisher","first-page":"100506","DOI":"10.1016\/j.conctc.2019.100506","volume":"17","author":"M Nicola","year":"2020","unstructured":"Nicola M, Weaver T, Pilling S, Goldsmith K, Carr E, Shearer J, Woolston-Thomas K, Tas B, Getty CA, Cooper C, van der Waal R, Kelleher M, Finch E, Bijral P, Taylor D, Scott J, Strang J. Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): study protocol for a feasibility study for an RCT of clinical and cost effectiveness. Contemporary Clinical Trials Communications. 2020;17:100506. https:\/\/doi.org\/10.1016\/j.conctc.2019.100506. ISSN 2451-8654.","journal-title":"Contemporary Clinical Trials Communications"},{"issue":"3","key":"1614_CR48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/dar.13555","volume":"42","author":"CA Getty","year":"2023","unstructured":"Getty CA, Weaver T, Metrebian N. A qualitative exploration of patients\u2019 experience of mobile telephone-delivered contingency management (mCM) to promote adherence to supervised methadone. Drug Alcohol Rev. 2023;42(3):641\u201351. https:\/\/doi.org\/10.1111\/dar.13555.","journal-title":"Drug Alcohol Rev"},{"key":"1614_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13314","author":"CA Getty","year":"2021","unstructured":"Getty CA, Weaver T, Lynskey M, Kirby KC, Dallery J, Metrebian N. Patients\u2019 beliefs towards contingency management: target behaviours, incentives and the remote application of these Interventions. Drug and Alcohol Review. 2021. https:\/\/doi.org\/10.1111\/dar.13314.","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"1614_CR50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09595239600185681","volume":"15","author":"M Adelekan","year":"1996","unstructured":"Adelekan M, Metrebian N, Tallack F, Stimson GV, Shanahan W. Who should collect opiate treatment index data in opiate treatment outcome monitoring: clinic staff or researchers? Drug Alcohol Rev. 1996;15(1):65\u201371.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"1614_CR51","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0962280215588242","volume":"25","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Costelloe CE, Kahan BC, Lancaster GA, Kerry SM. How big should the pilot study for my cluster randomised trial be? Stat Methods Med Res. 2016;25(3):1039\u201356. https:\/\/doi.org\/10.1177\/0962280215588242. Epub 2015 Jun 12 PMID: 26071431.","journal-title":"Stat Methods Med Res"},{"key":"1614_CR52","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1360-0443.1991.tb01706.x","volume":"86","author":"S Darke","year":"1991","unstructured":"Darke S, Heather N, Hall W, Ward J, Wodak A. Estimating drug consumption in opioid users: reliability and validity of a \u201crecent use\u201d episodes method. Br J Addict. 1991;86:1311\u20136.","journal-title":"Br J Addict"},{"key":"1614_CR53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction. 1993;88:791\u2013804.","journal-title":"Addiction"},{"key":"1614_CR54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1614_CR55","first-page":"733","volume":"87","author":"S Darke","year":"1992","unstructured":"Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Addiction. 1992;87(5):733\u201374217.","journal-title":"Addiction"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01614-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01614-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01614-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:45:10Z","timestamp":1742802310000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01614-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1614"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01614-8","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UK NHS Research ethics approval was granted by West Midlands\u2014Black Country Research Ethics Committee (23\/WM\/0098) on 23rd May 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NM has received, through her university, King\u2019s College London, research funding from Mundipharma Research Ltd (pharmaceutical company that produces a naloxone nasal spray). CAG has no competing interests. EC has no competing interests. TW has no competing interests. MK has taken part in industry sponsored research for Camurus, Indivior and Mundipharma. JSc has received payment from the College of Mental Health pharmacy for delivering training on their short course programme and for delivering a keynote talk at their 2023 conference. JS and SP have contributed to UK guidelines on the potential role of contingency management in the management of opioid addiction (NICE, 2007; convened by SP, chaired by JS), SP receives funding from NICE for the production of clinical guidelines. JS has chaired the broader-scope pan-UK working group preparing the 2017 and 2007 Orange Guidelines for the UK Departments of Health and Social Care, providing guidance on management and treatment of drug dependence and misuse, including guidance on possible inclusion of contingency management. JS is a researcher and clinician who, through his university, has worked\/is working with pharma and tech industries to identify new or improved interventions and his employer (King\u2019s College London) has received grants, travel costs and\/or consultancy payments; this includes discussion and investigation of new naloxone formulations with, past 3 years, Mundipharma, Accord and dne pharma (all of whom have naloxone products). His employer (King\u2019s College London) also earlier registered intellectual property on a buccal naloxone formulation, naming JS and colleagues, and he was previously named in a patent registration by a pharmaceutical company regarding concentrated nasal naloxone spray. JS does not receive any personal payment from these arrangements. JS has also worked with various drug policy organisations and advisory bodies including the Society for the Study of Addiction (SSA) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). JS was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King\u2019s College London. For a fuller account, see JS\u2019s web-page at .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}